Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Exited the position after management lowered 2025 financial guidance, citing delays onboarding centers, a postponed Medicare reimbursement code, marketing pauses, and some patient delays to try GLP-1 medications.
— Randy Gwirtzman
Full equity research memos, financial breakdowns, and hedge fund thesis write-ups are reserved for BSD Research ($50/mo) and Pro subscribers.
Already a Research or Pro subscriber? Sign In
Other investors who've written on Inspire Medical
No other institutional pitches found for this ticker yet.